Figure 1From: Prospective phase II study of preoperative short-course radiotherapy for rectal cancer with twice daily fractions of 2.9 Gy to a total dose of 29 Gy - Long-term resultsOverall survival (OS), cancer specific survival (CSS) and disease free survival (DFS).Back to article page